Perspective Therapeutics, Inc. (CATX): Net Income
-$103.12M
Year ended 2025-12-31
-$116.43M
Trailing 12 months to 2026-06-30
| Period ended | Net Income | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$103.12M | n/m | 2026-03-16, From 2025-01-01 |
| 2024-12-31 | -$79.28M | n/m | 2026-03-16, From 2024-01-01 |
| 2023-12-31 | -$46.51M | n/m | 2025-03-28, From 2023-01-01 |
| 2022-12-31 | -$10.76M | n/a | 2024-03-28, From 2022-01-01 |
| No annual figure between 2021-06-30 and 2022-12-31. | |||
| 2021-06-30 | -$3.39M | n/m | 2022-09-28, From 2020-07-01 |
| 2020-06-30 | -$3.45M | n/m | 2022-09-28, From 2019-07-01 |
| 2019-06-30 | -$5.14M | n/m | 2021-09-27, From 2018-07-01 |
| 2018-06-30 | -$6.70M | n/m | 2020-09-25, From 2017-07-01 |
| 2017-06-30 | -$6.16M | n/m | 2019-09-27, From 2016-07-01 |
| 2016-06-30 | -$4.71M | n/m | 2018-09-26, From 2015-07-01 |
| 2015-06-30 | -$3.68M | n/m | 2017-09-28, From 2014-07-01 |
| 2014-06-30 | -$5.96M | n/m | 2016-09-09, From 2013-07-01 |
| 2013-06-30 | -$3.86M | n/m | 2015-09-14, From 2012-07-01 |
| 2012-06-30 | -$3.49M | n/m | 2013-09-30, From 2011-07-01 |
| 2011-06-30 | -$2.84M | n/a | 2012-10-26, From 2010-07-01 |
Net Income at similar companies
| Company | Year ended | Net Income | Change YoY |
|---|---|---|---|
| Perspective Therapeutics, Inc. (CATX) | 2025-12-31 | -$103.12M | n/m |
| Arcturus Therapeutics Holdings Inc. (ARCT) | 2025-12-31 | -$65.78M | n/m |
| Nature's Sunshine Products Inc (NATR) | 2025-12-31 | $20.45M | +159.1% |
| Damora Therapeutics, Inc. (DMRA) | 2025-12-31 | -$209.84M | n/m |
| Phathom Pharmaceuticals, Inc. (PHAT) | 2025-12-31 | -$221.25M | n/m |
| Contineum Therapeutics, Inc. (CTNM) | 2025-12-31 | -$59.98M | n/m |
| Assembly Biosciences, Inc. (ASMB) | 2025-12-31 | -$6.12M | n/m |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 2025-12-31 | -$124.02M | n/m |
| Macrogenics Inc (MGNX) | 2025-12-31 | -$74.62M | n/m |
Compare CATX, ARCT, NATR, DMRA side by side · Screen every company in Pharmaceutical Preparations ↗